Objective
The aim of VIAV is to develop a highly innovative Env-based vaccine capable of inducing cross-clade neutralizing antibodies to prevent HIV infection.This represents the most important problem of current Env-based vaccines.VIAV aim will be achieved through new antigen design stemming out from novel virological, immunological and modeling data of the VIAV Consortium indicating that Tat increases HIV cell adsorption, infectivity and tropisms via a molecular mimicry of the CCR5 co-receptor.In fact,Tat binds the V3 loop of the HIV Env at the same residues binding the CCR5,allowing the generation and stabilization of complexes presenting cryptic and/or transiently exposed Env epitopes.These are crucial for inducing cross-clade neutralizing antibodies. In addition , R5 viruses are the major virus phenotype transmitted to healthy individuals.The goal of VIAV will be fulfilled through the achievement of specific objectives which, in turn, are the focus of specific workpackages: 1.Characterization of the Tat/V3loop com plex through the combined application of bioinformatics tools, NMR studies and microcalorimetry measurements 2.Generation,chemical-physical,immunological and biological characterization of Tat/Env complexes and their formulation for in vitro and in vivo s tudies 3.Evaluation of the safety and immunogenicity of different Tat/Env complex-based vaccine formulations in small animal models 4.Characterization of the specificity of the antibody responses generated in immunized animals 5.Characterization of virus-s pecific and cross-clade neutralizing activity of antibodies generated in immunized animals. The achievement of VIAV objectives will be implemented through a rigorous management of the scientific, business and administrative activities by the Steering Commi ttee and by the Project Coordinator. VIAV is linked to the AIDS Vaccine Integrated Project (AVIP),recently awarded by the EU Commission, for future product development and clinical testing
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2003-LIFESCIHEALTH-3
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
ROME
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.